BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35241692)

  • 21. Germline PTEN genotype-dependent phenotypic divergence during the early neural developmental process of forebrain organoids.
    Kang SC; Sarn NB; Venegas J; Tan Z; Hitomi M; Eng C
    Mol Psychiatry; 2023 Nov; ():. PubMed ID: 38030818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome.
    Bubien V; Bonnet F; Brouste V; Hoppe S; Barouk-Simonet E; David A; Edery P; Bottani A; Layet V; Caron O; Gilbert-Dussardier B; Delnatte C; Dugast C; Fricker JP; Bonneau D; Sevenet N; Longy M; Caux F;
    J Med Genet; 2013 Apr; 50(4):255-63. PubMed ID: 23335809
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Pilarski R
    Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31216739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and clinical/molecular characteristics of PTEN mutations in Turkish children with autism spectrum disorders and macrocephaly.
    Kaymakcalan H; Kaya İ; Cevher Binici N; Nikerel E; Özbaran B; Görkem Aksoy M; Erbilgin S; Özyurt G; Jahan N; Çelik D; Yararbaş K; Yalçınkaya L; Köse S; Durak S; Ercan-Sencicek AG
    Mol Genet Genomic Med; 2021 Aug; 9(8):e1739. PubMed ID: 34268892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The microbiome in
    Byrd V; Getz T; Padmanabhan R; Arora H; Eng C
    Endocr Relat Cancer; 2018 Mar; 25(3):233-243. PubMed ID: 29233840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comprehensive functional analysis of PTEN mutations: implications in tumor- and autism-related syndromes.
    Rodríguez-Escudero I; Oliver MD; Andrés-Pons A; Molina M; Cid VJ; Pulido R
    Hum Mol Genet; 2011 Nov; 20(21):4132-42. PubMed ID: 21828076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Broad spectrum of neuropsychiatric phenotypes associated with white matter disease in PTEN hamartoma tumor syndrome.
    Balci TB; Davila J; Lewis D; Boafo A; Sell E; Richer J; Nikkel SM; Armour CM; Tomiak E; Lines MA; Sawyer SL
    Am J Med Genet B Neuropsychiatr Genet; 2018 Jan; 177(1):101-109. PubMed ID: 29152901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An Integrated Deep-Mutational-Scanning Approach Provides Clinical Insights on PTEN Genotype-Phenotype Relationships.
    Mighell TL; Thacker S; Fombonne E; Eng C; O'Roak BJ
    Am J Hum Genet; 2020 Jun; 106(6):818-829. PubMed ID: 32442409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Clinical Spectrum of
    Yehia L; Keel E; Eng C
    Annu Rev Med; 2020 Jan; 71():103-116. PubMed ID: 31433956
    [No Abstract]   [Full Text] [Related]  

  • 30. Thyroid nodules and cancer in children with PTEN hamartoma tumor syndrome.
    Smith JR; Marqusee E; Webb S; Nose V; Fishman SJ; Shamberger RC; Frates MC; Huang SA
    J Clin Endocrinol Metab; 2011 Jan; 96(1):34-7. PubMed ID: 20962022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hamartoma-like lesions in the mouse retina: an animal model of
    Tachibana N; Touahri Y; Dixit R; David LA; Adnani L; Cantrup R; Aavani T; Wong RO; Logan C; Kurek KC; Schuurmans C
    Dis Model Mech; 2018 May; 11(5):. PubMed ID: 29716894
    [No Abstract]   [Full Text] [Related]  

  • 32. PTEN hamartoma tumour syndrome: what happens when there is no PTEN germline mutation?
    Yehia L; Eng C
    Hum Mol Genet; 2020 Oct; 29(R2):R150-R157. PubMed ID: 32568377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. WWP1 Gain-of-Function Inactivation of PTEN in Cancer Predisposition.
    Lee YR; Yehia L; Kishikawa T; Ni Y; Leach B; Zhang J; Panch N; Liu J; Wei W; Eng C; Pandolfi PP
    N Engl J Med; 2020 May; 382(22):2103-2116. PubMed ID: 32459922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased prevalence of eosinophilic gastrointestinal disorders in pediatric PTEN hamartoma tumor syndromes.
    Henderson CJ; Ngeow J; Collins MH; Martin LJ; Putnam PE; Abonia JP; Marsolo K; Eng C; Rothenberg ME
    J Pediatr Gastroenterol Nutr; 2014 May; 58(5):553-60. PubMed ID: 24345843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutation-positive and mutation-negative patients with Cowden and Bannayan-Riley-Ruvalcaba syndromes associated with distinct 10q haplotypes.
    Pezzolesi MG; Li Y; Zhou XP; Pilarski R; Shen L; Eng C
    Am J Hum Genet; 2006 Nov; 79(5):923-34. PubMed ID: 17033968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Implications for Germline PTEN Spectrum Disorders.
    Ngeow J; Sesock K; Eng C
    Endocrinol Metab Clin North Am; 2017 Jun; 46(2):503-517. PubMed ID: 28476234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chiari I malformation in a child with PTEN hamartoma tumor syndrome: Association or coincidence?
    Saletti V; Esposito S; Maccaro A; Giglio S; Valentini LG; Chiapparini L
    Eur J Med Genet; 2017 May; 60(5):261-264. PubMed ID: 28286253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histopathological phenotyping of cancers in PTEN Hamartoma Tumor Syndrome for improved recognition: A single-center study.
    Schei-Andersen AJ; Hendricks LAJ; van der Post RS; Mensenkamp AR; Schieving J; ; Schuurs-Hoeijmakers JHM; Hoogerbrugge N; Vos JR
    Int J Cancer; 2024 Jun; ():. PubMed ID: 38861330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functionally distinct groups of inherited PTEN mutations in autism and tumour syndromes.
    Spinelli L; Black FM; Berg JN; Eickholt BJ; Leslie NR
    J Med Genet; 2015 Feb; 52(2):128-34. PubMed ID: 25527629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breast cancer risk and clinical implications for germline PTEN mutation carriers.
    Ngeow J; Sesock K; Eng C
    Breast Cancer Res Treat; 2017 Aug; 165(1):1-8. PubMed ID: 26700035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.